Group A streptococcal disease in paediatric inpatients: a European perspective

Navin P Boeddha1,2, Lucy Atkins3, Ronald de Groot4

  • 1Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Insights

Group A streptococcal (GAS) infections are increasing globally, causing severe illness and disability in hospitalized children. Early recognition and prevention strategies for GAS disease are crucial for better outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Clinical Microbiology

Background:

  • Group A streptococcal (GAS) infections show increasing incidence worldwide, with limited epidemiological data in European children.
  • GAS is the most frequent pathogen in children hospitalized with community-acquired bacterial infections in Europe.

Purpose of the Study:

  • To characterize children hospitalized with GAS infection in European hospitals.
  • To identify risk factors for disease severity and disability in pediatric GAS infections.

Main Methods:

  • Prospective, multicentre, cohort study of 320 children (1 month to 18 years) across 6 European countries (2012-2016).
  • Data collection included demographics, clinical presentation, microbiology, and outcomes.
  • GAS detection from normally sterile sites and common infection sites (LRTI, SSTI, bone/joint) were analyzed.

Main Results:

  • 61% of patients had sepsis, and 74% had GAS detected from sterile sites.
  • Lower respiratory tract infections (LRTI) and infections without a clear focus were more common in pediatric intensive care unit (PICU) admissions.
  • Hospital discharge showed 12% overall disability, primarily in PICU patients, including neurodisability and amputation. 2% mortality was observed.

Conclusions:

  • GAS infection remains a significant cause of severe disease and morbidity in hospitalized children, despite advances in other vaccine-preventable infections.
  • Younger children are particularly vulnerable to severe outcomes, including short- and long-term disability.
  • Further research is needed to improve prevention and early detection of GAS disease.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
29
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
457
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
29